Jong-Hyeon Park

center for foot-and-mouth disease vaccine research

H指数:27

被引数:2,024

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Development of a Recombinant O/CATHAY Topotype Foot-and-Mouth Disease Virus as a Resource for Vaccine Matching and Efficacy Evaluation

重组O/CATHAY拓扑型口蹄疫病毒的开发：作为疫苗匹配和效力评价的资源

Viruses-Basel

IF3.5

2026-09-160

Novel Thermostabilizing Formulation for Enhanced Stability of Foot-and-Mouth Disease Virus During Storage and Environmental Stress

新型热稳定配方用于提高口蹄疫病毒在储存和环境压力下的稳定性

Microorganisms

IF4.2

2026-09-150

Functional Evaluation of Neutralizing Antibodies Against Foot-and-Mouth Disease Virus Serotype O Using a Luciferase-Based Surrogate Neutralization Assay

利用基于荧光素酶的替代中和试验评估针对口蹄疫病毒O型血清的中和抗体功能

Viruses-Basel

IF3.5

2026-09-150

Intradermal Vaccination Induces Protective Immunity Against Foot-and-Mouth Disease While Mitigating Milk Yield Reduction in Ruminants

皮内疫苗接种可诱导抗口蹄疫的保护性免疫，同时缓解反刍动物奶产量下降

Vaccines

IF3.4

2026-08-130

Evaluation of Antigen Productivity and Inactivation Kinetics of a Recombinant Foot-and-Mouth Disease SAT1 Vaccine Strain

重组口蹄疫SAT1疫苗株的抗原生产力和灭活动力学评价

Viruses

IF3.5

2026-05-070

OAAI

Evaluation of an In-House Developed Foot-and-Mouth Disease Virus SAT 3 Vaccine Strain Based on Antigen Productivity and Inactivation Kinetics for Commercial Feasibility

基于抗原生产力和灭活动力学对一种内部开发的口蹄疫病毒SAT 3疫苗株进行商业可行性评估

Vaccines

IF3.4

2026-04-270

Enhancing Capsid Stability of a Foot-and-Mouth Disease Virus Vaccine Strain Through VP1-Directed Chimeric Design While Preserving Antigenicity

通过VP1定向嵌合设计增强口蹄疫病毒疫苗株的衣壳稳定性同时保留抗原性

Vaccines

IF3.4

2026-04-220

Development and immunogenicity of adenoviral Fc-fused FMDV virus-like particle vaccine in swine

腺病毒Fc融合FMDV病毒样颗粒疫苗在猪中的开发与免疫原性

VETERINARY QUARTERLY

IF5.2

2025-12-310

PRE

Characterization of a Virus Rescued from a Full-Length Infectious Clone Derived from the Type A Foot-and-Mouth Disease Virus Isolated in South Korea

源自韩国分离的A型口蹄疫病毒全长感染性克隆拯救病毒的表征

Viruses 2025, Vol. 17, Page 1561

IF3.5

2025-11-290

OAAI

Construction of a Full-Length Infectious Clone Derived from Type O Foot-And-Mouth Disease Virus Isolated in South Korea for Vaccine Development with High Antigen Productivity

从韩国分离的O型口蹄疫病毒构建高抗原产量疫苗开发的全长感染性克隆

Vaccines 2025, Vol. 13, Page 1195

IF3.4

2025-11-270

OAAI

Development of a Chimeric Vaccine Providing Protection Against the Type A ASIA/Sea-97 FMDVs in East Asia

开发一种针对东亚地区A型ASIA/Sea-97 FMDV的嵌合疫苗，提供保护作用

Vaccines 2025, Vol. 13, Page 1104

IF3.4

2025-10-290

OAAI

Evaluation of Recombinant Foot-and-Mouth Disease SAT2 Vaccine Strain in Terms of Antigen Productivity, Virus Inactivation Kinetics, and Immunogenicity in Pigs for Domestic Antigen Bank

重组口蹄疫SAT2疫苗株在抗原产量、病毒灭活动力学及猪免疫原性方面的评价，用于国内抗原库。

Vaccines 2025, Vol. 13, Page 704

IF3.4

2025-08-230

PRE

Immunostimulatory effects of multiple short-hairpin RNAs enhance foot-and-mouth disease vaccine-induced humoral immunity

多种短发夹状RNA的免疫刺激效应增强了口蹄疫疫苗诱导的体液免疫

Antiviral Research

IF4

2025-05-270

PRE

Neutralizing Antibody Screening Using NanoBiT-Based Virus-like Particles of Foot-and-Mouth Disease Type Asia1 Enhances Biosafety and Sensitivity

VIRUSES-BASEL

IF3.5

2025-02-270

OAAI

Oral administration of glycyrrhizic acid with intramuscular injection of foot-and-mouth disease vaccine enhances the adaptive immune system

FRONTIERS IN MICROBIOLOGY

IF4.5

2025-02-190

OAAI

Levamisole, as a viral vaccine adjuvant, induces robust host defense through the modulation of innate and adaptive immune responses

FRONTIERS IN MICROBIOLOGY

IF4.5

2025-01-080

OAAI

Next-generation adjuvant systems containing furfurman drives potent adaptive immunity and host defense as a foot-and-mouth disease vaccine adjuvant

FRONTIERS IN IMMUNOLOGY

IF5.9

2024-12-110

OAAI

Oral Administration of Zinc Sulfate with Intramuscular Foot-and-Mouth Disease Vaccine Enhances Mucosal and Systemic Immunity

VACCINES

IF3.4

2024-11-090

OAAI

Enhanced Effects of ISA 207 Adjuvant via Intradermal Route in Foot-and-Mouth Disease Vaccine for Pigs

VACCINES

IF3.4

2024-08-260

OAAI

Establishment of the Foot-and-Mouth Disease Virus Type Asia1 Expressing the HiBiT Protein: A Useful Tool for a NanoBiT Split Luciferase Assay

VIRUSES-BASEL

IF3.5

2024-06-211

OAAI

Jong-Hyeon Park

个人简介

教育背景

工作经历

荣誉奖项

研究方向